SEC Form D · filed December 22, 2021
Bonum Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Neela Patel · Seattle, WAExecNicholas Walrod · Seattle, WADirectorJohn Mulligan · Seattle, WAExec · Director · PromoterDiane Hollenbaugh · Seattle, WAExecKarl Handelsman · Seattle, WADirectorMonique Schiersing · Seattle, WADirectorJohn Mckearn · Seattle, WADirectorBlueArc Global Alternatives Management, LLC · Atlanta, GAExecWashington Harbour Partners, LP · ARLINGTON, VADirectorMadison Avenue Financial Solutions, LLC · Chicago, ILDirectorJonathan Wells · Mt Pleasant, SCDirectorSteven G. Lentz · Minneapolis, MNDirectorHeston Berkman · Orlando, FLExecMasahiro Koshiba · Minato-ku, Tokyo, M0Exec · Director · PromoterFriends & Family Capital Management, LLC · MENLO PARK, CADirectorPaul Carram · Hoboken, NJExecCarlos Batista · Hoboken, NJExecDaniel Mingle · Sandy, UTDirectorDaniel Freeman · Ithaca, NYDirectorScott Lewis · Golden, CODirectorKimberly J. Melen · Grand Cayman, Cayman IslandsExec · Director · Promoter Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗